| 42.76 Delayed Data As of Jun 14 |  +0.26 / +0.61%Today’s Change | 35.73 Today|||52-Week Range 46.47 | -2.04% Year-to-Date |
| Previous close | 42.50 |
| Today’s open | 42.52 |
| Day’s range | 42.48 - 42.87 |
| Volume | 12,521,887 |
| Average volume (3 months) | 22,709,104 |
| Market cap | $237.7B |
| Earnings growth (last year) | -46.78% |
| Earnings growth (this year) | -3.03% |
| Earnings growth (next 5 years) | +5.98% |
| Revenue growth (last year) | +2.10% |
| P/E ratio | 21.9 |
| Price/Sales | 4.86 |
| Price/Book | 3.86 |
| Today’s change | Today’s % change | |
|---|---|---|
| MRKMerck | +0.43 | +0.52% |
| NVSNovartis | -0.07 | -0.08% |
| ABTAbbott Laboratories | -0.07 | -0.09% |
| ABBVAbbVie | -0.26 | -0.33% |
| Next reporting date | July 30, 2019 |
| EPS forecast (this quarter) | $0.75 |
| Annual revenue (last year) | $53.6B |
| Annual profit (last year) | $11.2B |
| Net profit margin | 20.77% |
Sector Health Technology |
Industry Pharmaceuticals: Major |
Director, Chief Executive & Operating Officer Albert Bourla |
Chief Financial Officer & EVP-Business Operations Frank A. D'Amelio |
Corporate headquarters New York, New York |
